After questions and criticism online, Janelle Rohner says she should have disclosed her decision to take a GLP-1.

Newly recognized issues, including extreme fatigue with excessive weight reduction, bone loss, and abdominal pain, point to ...

Xavier said that patients are often reluctant to quit smoking because they are fearful that they will gain weight. By adding ...

New review confirms psychiatric safety of commonly used glucagon-like peptide 1 receptor agonists among patients without ...

VinFuture Prize holds the distinction of being the first major international science and technology award to recognize and ...

Cigna subsidiary Evernorth Health Services will automate prior authorizations for GLP-1 weight-loss drugs under a new program ...

KANSAS CITY, MISSOURI, US — Already on the path toward healthier, nutrient-dense products, the increasing popularity of GLP-1 ...

GLP-1 receptor agonists are associated with improvements in restrained eating, emotional eating behavior, QOL.

The companies are allegedly selling "research grade" GLP-1 weight loss drugs that are not FDA-approved, and are selling the products without a pharmacy license.

After the the FDA declared an end to the shortage of GLP-1 medications, compounded versions of the drug must be out of the market by Thursday. (Scripps News) ...

CheqUp is a leading provider of medically supervised weight loss programmes, offering personalised treatment plans, clinical oversight, and one-on-one coaching. CheqUp empowers individuals to take ...

After the the FDA declared an end to the shortage of GLP-1 medications, compounded versions of the drug must be out of the market by Thursday.